Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Growth Forecast Through 2030: Market Size And Trends In 2026
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The robot-assisted percutaneous coronary intervention (pci) market size has experienced substantial growth in recent years. This market is projected to expand from $27.56 billion in 2025 to $38.73 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 40.5%. Historically, the market’s expansion can be attributed to factors such as an increase in coronary artery disease prevalence, the inherent limitations of manual pci precision, the growing adoption of catheter-based interventions, heightened awareness regarding radiation risks, and the proliferation of cardiac catheterization laboratories.
The robot-assisted percutaneous coronary intervention (pci) market size is projected to experience rapid expansion in the coming years. It will grow to $149.68 billion in 2030 at a compound annual growth rate (CAGR) of 40.2%. This expansion during the projection period stems from progress in robotic-assisted intervention technologies, greater integration of automation within cardiology, increased capital allocation for digital healthcare infrastructure, a surging need for intricate and high-risk PCI procedures, and favorable regulatory endorsements for robotic platforms. Key trends anticipated during the forecast period encompass a growing uptake of minimally invasive cardiac interventions, a heightened emphasis on lowering radiation exposure for medical professionals, a greater call for exactness and accuracy in procedures, an broadening of complex coronary intervention abilities, and enhanced patient safety with improved clinical results.
Get A Free Sample Report With In-Depth Market Insights:
Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Industry Drivers: What’s Behind The Revenue Growth?
The robot-assisted percutaneous coronary intervention (PCI) market is projected to expand due to the rising incidence of cardiovascular diseases. These diseases encompass various heart and blood vessel disorders, such as coronary artery disease, heart attacks, and stroke. A primary factor contributing to the increase in cardiovascular ailments is sedentary lifestyles, which can result in obesity, high blood pressure, and diminished heart health. Robot-assisted percutaneous coronary intervention (PCI) offers a solution for cardiovascular diseases by precisely clearing obstructed or constricted coronary arteries, thereby reestablishing blood flow to the heart, minimizing procedural dangers and radiation, and ultimately improving patient results. As an illustration, GOV.UK, a UK government body, stated in December 2024 that by March 2024, approximately 2.24 million adults in England, representing about 4.4% of individuals aged 18 and over, had a GP diagnosis of CKD, marking an increase from 2.09 million cases reported in the preceding year. Consequently, the rising occurrence of cardiovascular diseases is a key factor propelling the expansion of the robot-assisted percutaneous coronary intervention (PCI) market.
Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Breakdown By Product Type And Application
The robot-assisted percutaneous coronary intervention (pci) market covered in this report is segmented –
1) By Component: Robotic Systems, Catheters And Guidewires, Control Consoles
2) By Application: Coronary Angioplasty, Stent Placement, Thrombectomy
3) By End-User: Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Robotic Systems: Electromechanical Robotic Arms, Imaging Integration Units, Robotic Drive Systems
2) By Catheters And Guidewires: Coronary Guidewires, Balloon Catheters, Drug-Eluting Catheters
3) By Control Consoles: Touchscreen Interfaces, Joystick Controllers, Imaging Display Panels
#Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies in the robot-assisted percutaneous coronary intervention (PCI) market are prioritizing the development of sophisticated robotic cardiologist platforms to enhance patient safety and simplify complex coronary interventions. A robotic cardiology platform is an advanced technological system designed to assist cardiologists in performing accurate and controlled coronary procedures, thereby increasing precision, minimizing human error, and reducing radiation exposure for both patients and medical personnel. For example, in May 2023, Robocath SAS, a France-based company specializing in robotic solutions for vascular interventions, introduced the R-One+. This advanced robotic solution allows interventional cardiologists to perform coronary angioplasties (percutaneous coronary intervention, or PCI) by controlling devices through an integrated command unit located in either the catheterization lab or a control room. The R-One+ improves precision in device manipulation, boosts safety for both patients and medical staff by lowering radiation exposure, and provides more comfortable working conditions for operators. The launch was announced at the EuroPCR conference in Paris, where the platform demonstrated new capabilities that make PCI procedures simpler and safer while protecting the cardiology team from radiation-induced injuries. This innovation highlights Robocath’s dedication to enhancing cardiovascular disease treatments with intelligent robotic assistance.
Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Competitive Overview And Top Companies
Major companies operating in the robot-assisted percutaneous coronary intervention (pci) market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Intuitive Surgical, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Stereotaxis Inc., Perfint Healthcare, Robocath Inc., Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Philips Healthcare, Terumo Corporation, Asahi Intecc, Catheter Precision, Cardiobot, Remedics, meerecompany Inc., AngioDynamics, Clear Surgical Inc., GE Healthcare, Canon Medical Systems, Asensus Surgical, Endovascular Robotics
View The Full Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Report:
Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the robot-assisted percutaneous coronary intervention (PCI) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robot-assisted percutaneous coronary intervention (pci) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
